The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Stevens-Johnson Syndrome Induced by Carbamazepine Treatment in a Patient Who Previously Had Carbamazepine Induced Pruritus - A Case Report -

  • Bae, Hyun Min (Department of Anesthesiology and Pain Medicine, Catholic Medical Center, School of Medicine, The Catholic University of Korea) ;
  • Park, Yoo Jung (Department of Anesthesiology and Pain Medicine, Catholic Medical Center, School of Medicine, The Catholic University of Korea) ;
  • Kim, Young Hoon (Department of Anesthesiology and Pain Medicine, Catholic Medical Center, School of Medicine, The Catholic University of Korea) ;
  • Moon, Dong Eon (Department of Anesthesiology and Pain Medicine, Catholic Medical Center, School of Medicine, The Catholic University of Korea)
  • Received : 2012.09.10
  • Accepted : 2012.10.16
  • Published : 2013.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Stevens-Johnson syndrome (SJS) is a rare but life-threatening skin reaction disease and carbamazepine is one of its most common causes. We report a case of SJS secondary to carbamazepine in a patient with previous pruritus due to carbamazepine which was given for treatment of trigeminal neuralgia. We would like to caution all providers that carbamazepine readministration should be avoided in the patient with a previous history of SJS or adverse skin reaction. In addition, we strongly recommend gradual titration when initiating treatment with carbamazepine.

Keywords

References

  1. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens- Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019-24.
  2. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64: 1134-8. https://doi.org/10.1212/01.WNL.0000156354.20227.F0
  3. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134: 710-4. https://doi.org/10.1111/j.1365-2133.1996.tb06976.x
  4. Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998; 39 Suppl 7: S8-16. https://doi.org/10.1111/j.1528-1157.1998.tb01679.x
  5. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997; 49: 542-6. https://doi.org/10.1212/WNL.49.2.542
  6. Larsen A, Piepgras D, Chyatte D, Rizzolo D. Trigeminal neuralgia: diagnosis and medical and surgical management. JAAPA 2011; 24: 20-5.
  7. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 2005; 94: 419-36. https://doi.org/10.1016/S1081-1206(10)61112-X
  8. Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine-- the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years. Indian J Dermatol Venereol Leprol 2005; 71: 325-8. https://doi.org/10.4103/0378-6323.16782
  9. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCARstudy. J Invest Dermatol 2008; 128: 35-44. https://doi.org/10.1038/sj.jid.5701033
  10. Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 2006; 118: 233-41. https://doi.org/10.1016/j.jaci.2006.03.005
  11. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85. https://doi.org/10.1056/NEJM199411103311906
  12. Huang LY, Liao WC, Chiou CC, Lou JP, Hu P, Ko FC. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepineinduced Stevens-Johnson syndrome. J Formos Med Assoc 2007; 106: 1032-7. https://doi.org/10.1016/S0929-6646(08)60079-0
  13. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58: 25-32. https://doi.org/10.1016/j.jaad.2007.08.036

Cited by

  1. Carbamazepine vol.1450, pp.1, 2013, https://doi.org/10.1007/s40278-013-2799-1
  2. Analysis of Drugs Causing Severe Cutaneous Adverse Reactions, Based on the Korean Database of Spontaneously Reported Adverse Drug Reactions vol.86, pp.6, 2014, https://doi.org/10.3904/kjm.2014.86.6.710